Subscribe free

HPB & Spleen ·

Surgeons’ Insights on Pancreatic Cancer Cure Rates

Surgical resection significantly increases cure probabilities for pancreatic ductal adenocarcinoma.

  • Cure probability for patients undergoing resection is 25.24%, compared to 6.82% for those who do not.
  • Neoadjuvant chemotherapy before surgery improves cure rates (30.0% vs 17.05% with upfront surgery).

Earlier detection and combined treatment strategies are crucial for improving long-term outcomes.

  • Cure probabilities decrease with older age and advanced clinical stage, underscoring the need for timely intervention.

Journal Article by Elshami M, Pawar OS and Winter JM in BMC Surg

Copyright © 2026 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →